Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-09-08

Clinical Trial Update: Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Atenas Association for Type II diabetes mellitus and hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenas Association

Snippet

Sponsor: EMS | Conditions: Hypertension Associated, Type II Diabetes Mellitus | Phase 3 | Status: WITHDRAWN